Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
USPTO Backlog Impacts Biopharma Industry
Unless Situation Is Resolved, Investment in New Candidates May Be Delayed or Withheld
- Large pharmaceutical companies are increasingly turning to smaller biotechnology and pharmaceutical companies to supplement their drug development pipelines. When deciding whether to invest in a start-up or smaller firm, the acquiring company faces two major uncertainties: (1) Will a promising early-stage compound gain approval from the FDA? and (2) ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.